Forward Citations = 26

Loading Chart...

1 inventor (with patents filed for the assignee):

Knox Van Dyke (5 out of 12 patents)

5 patents: Sort by Forward Citations

1. 6962927 - Method for potentiating primary drugs in treating multidrug resistant disease (2005-11-08),

2. 6911454 - Method for potentiating primary drugs in treating multidrug resistant disease (2005-06-28),

3. 6124315 - Method for potentiating primary drugs in treating multidrug resistant (2000-09-26),

4. 5332747 - Method for potentiating primary drugs in treating multidrug resistant (1994-07-26),

5. 5025020 - Use of tetrandrine and its derivatives to treat malaria (1991-06-18),

Cancer Biologics of America, Inc. is a leading biotechnology company focused on developing innovative cancer treatments. Our mission is to improve the lives of cancer patients by creating targeted biologic therapies that harness the power of the immune system to fight cancer. With a strong pipeline of novel biologics in development, we are committed to advancing the field of immuno-oncology and bringing new treatment options to patients in need.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

5 Patents

#32 in Lexington, KY

#271 in Kentucky

#50,171 in US

Lexington, KY, United States of America

Cancer Biologics of America, Inc.

Forward Citations = 26

1 inventor:

Knox Van Dyke (5 out of 12 patents)

Please report any incorrect information to support@idiyas.com